Blue Cross Blue Shield of Texas Medicare and Medicaid are leaving MD Anderson. Here's what that means
By Nov. 1, MD Anderson's agreement with Blue Cross Blue Shield Medicare Advantage will expire, leaving patients on that plan ...
Click2Houston16h
Blue Cross and Blue Shield of Texas to remove Houston’s MD Anderson Cancer Center from Medicare, Medicaid networks
Blue Cross and Blue Shield of Texas announced it has made the decision to remove MD Anderson Cancer Center in Houston from ...
MD Anderson's annual Boot Walk takes place Saturday, November 2nd
One of the many patients who left MD Anderson cancer free, Rachel Cruz Auwarter, is now paying it forward as one of the top ...
MedPage Today on MSN23h
Precision Medicine Approach Shows Promise for Anaplastic Thyroid Cancer
Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...
News Medical on MSN2d
Targeted therapy and immunotherapy improve outcomes in rare thyroid cancer
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination ...
BCBS of Texas removes MD Anderson Cancer Center from its Medicare Advantage and Medicaid networks
Blue Cross and Blue Shield of Texas said MDA will no longer be in its Medicare Advantage (PPO)SM or Blue Cross Medicare Advantage (HMO)SM as of Nov. 1, 2024.
BlackDoctor1d
Is Streaming TV Fueling a New Smoking Epidemic? What You Need to Know
A recent study delves into the subtle ways that tobacco and smoking use is being promoted on streaming platforms.
MD Anderson Cancer Center's Allison Institute receives $5 million gift
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Medscape2d
Should First-Line Dual Checkpoint Blockade Be Used for NSCLC With Specific Mutations?
Researchers conducted a subgroup analysis of POSEIDON trial data, then characterized underlying biologic mechanisms using mouse models.